we present evidence that acute mitochondrial dysfunction activates airway sensory nerves preferentially via TRPA1 through the actions of mitochondrially-derived ROS. This represents a novel mechanism by which inflammation may be transduced into nociceptive electrical signaling.
Introduction
There is growing evidence that mitochondrial dysfunction contributes to the complex mechanisms of multiple diseases. In addition to diseases of inherited and spontaneous mutations in nuclear or mitochondrial DNA (leading to altered mitochondrial protein expression) (Copeland, 2008) , increased mitochondrial reactive oxygen species (ROS) production is thought to contribute to chronic inflammatory disease states such as type II diabetes mellitus, cardiovascular disease, asthma and irritable bowel syndrome (Chowdhury et al., 2012; Hall and Wiley, 1998; Reddy, 2011; Rocha et al., 2010) .
Mitochondria are present in the vast majority of nucleated cells including sensory nerves. ATP production is coupled to oxygen reduction by electron transport chain (ETC) proteins of the mitochondrial inner membrane. During normal physiological conditions approximately 2% of oxygen undergoes incomplete reduction and produces the ROS superoxide. Inefficiencies of ETC proteins in complex I and III lead to excess superoxide production and, through a series of reactions, the downstream formation of ROS and lipid peroxidation products (e.g. 4-hydroxynonenal) (Karihtala and Soini, 2007) . Although the mechanism of mitochondrial dysfunction in chronic inflammatory diseases is not well understood, numerous inflammatory signaling pathways increase mitochondrial ROS production: either (i) through the inhibition of complex I or III: e.g. TNFα (Corda et al., 2001) , neurotrophins via p75NTR (Pehar et al., 2007) , and Toll-like Receptors (West et al., 2011) ; or (ii) through downregulation of mitochondrial antioxidant enzymes by microRNAs (Aroor et al., 2012) and TGFβ (Michaeloudes et al., 2010) .
In the respiratory system, mitochondrial dysfunction and oxidative stress has been described in airway epithelial and smooth muscle cells in asthma and chronic obstructive pulmonary disease (COPD) (Aguilera-Aguirre et al., 2009; Mabalirajan et al., 2008; Rabinovich et al., 2007) . The M O L # 8 4 3 1 9 5 airways and lungs are densely innervated with vagal sensory nerves. Interestingly, the peripheral terminals of these nerves, which innervate the submucosal and epithelial layers of the airways, contain a high density of mitochondria (Hung et al., 1973; von During and Andres, 1988) . The vast majority of airway sensory nerves are "nociceptive": i.e they serve to protect the airways through the initiation of reflexes (cough, hypersecretion, bronchospasm) and sensations (dyspnea, itch, urge to cough) (Carr and Undem, 2003) . As such there is considerable interest in understanding the mechanisms through which inflammation and other noxious stimuli activate these nerves and induce debilitating morbidity. Airway nociceptive nerves selectively express ion channels such as transient receptor potential vanilloid 1 (TRPV1) (Kollarik et al., 2003) and transient receptor potential ankyrin 1 (TRPA1) (Nassenstein et al., 2008) which are activated by inflammatory mediators, oxidative stress and downstream products of lipid peroxidation (Patapoutian et al., 2009) . Previous studies have shown that activation of TRPV1 or TRPA1 leads to airway nociceptor-induced reflexes and thus produces symptoms similar to airway diseases (Andre et al., 2008; Carr and Undem, 2003; Forsberg et al., 1988) . Based on the anatomical co-localization of mitochondria and TRP channels in peripheral nerve terminals, we propose that sensory nerve terminal mitochondrial modulation is linked to sensory nerve activation. Here we show that acute mitochondrial modulation activates airway vagal nociceptors predominantly through the gating of TRPA1 channels.
Materials and Methods
All experiments were approved by the University of South Florida Institutional Animal Care and Use Committee.
Dissociation of mouse vagal ganglia: Male mice were killed by CO 2 asphyxiation followed by exsanguination. Vagal ganglia were immediately isolated and enzymatically dissociated from This article has not been copyedited and formatted. The final version may differ from this version. Bronchopulmonary C-fiber extracellular recordings: Male mice were killed by CO 2 asphyxiation followed by exsanguination. The innervated isolated lung preparation was prepared as previously described (Taylor-Clark et al., 2009; Taylor-Clark et al., 2008a) . Briefly, the airways and lungs with their intact extrinsic innervation (vagus nerve including vagal ganglia)
were taken and placed in a dissecting dish containing Krebs bicarbonate buffer solution composed of (mM): 118 NaCl, 5.4 KCl, 1.0 NaH 2 PO 4 , 1.2 MgSO 4 , 1.9 CaCl 2 , 25.0 NaHCO 3 and 11.1 D-glucose, and equilibrated with 95% O 2 and 5% CO 2 (pH 7.3-7.4). Connective tissue was trimmed away leaving the trachea and lungs with their intact nerves. The airways were then pinned to the larger compartment of a custom-built two-compartment recording chamber that was lined with silicone elastomer (Sylgard). A vagal ganglion was pulled into the adjacent compartment of the chamber through a small hole and pinned. Both compartments were separately superfused with Krebs bicarbonate buffer (37°C . Due to a lack of TRPV1 channels in bronchopulmonary C-fibers from TRPV1-/-mice, 'nociceptive' status was assessed solely by conduction velocity and the response to TRPA1 agonists (Kollarik et al., 2003; Nassenstein et al., 2008) . Due to the irreversible inhibition of complex III by antimycin (Potter and Reif, 1952; Slater, 1973; Stowe and Camara, 2009; Turrens et al., 1985) , only one antimycin A treatment was used per preparation.
Due to potential heterologous desensitization, capsaicin was only given at the end of each experiment. All excitatory chemical treatments were separated by at least 15 mins wash. Action potential discharge was quantified off-line and recorded in 1 s bins. A response was considered positive if the number of action potentials in any 1 s bin was twice the average background response. The background activity was usually either absent or less than 2 Hz. The peak frequency evoked by a stimulus was quantified as the maximum number of action potentials that occurred within any 1 s bin.
This article has not been copyedited and formatted. The final version may differ from this version. -data was presented as the percentage change in 340nm/380nm ratio (R): response at time (x) = 100 X (R x -R bl )/(R max -R bl ), where R x was the 340nm/380nm ratio of the cell at a given time point, R bl was the cell's mean baseline 340nm/380nm ratio measured over 60s, and R max was the cell's peak 340nm/380nm ratio. This normalization allows for quantitative comparisons between cells (Taylor-Clark et al., 2009; Taylor-Clark et al., 2008a; Taylor-Clark et al., 2008b whole-cell (3-5 MΩ) or perforated patch recording (1-3 MΩ) were filled with solution composed of (mM): 130 CsCl, 1 CaCl2, 2 MgCl2, 10 HEPES, 10 dextrose, 11 EGTA and 5 Na-triphosphate adjusted to pH 7.2 with NaOH. Na-triphosphate was used to prevent rundown of TRPA1
responses (Kim and Cavanaugh, 2007) . Perforation was achieved using 5 μg/ml gramicidin.
Cells on a coverslip were superfused at 8 mL/min with HEPES-buffered bath solution (composition (mM)): 154 NaCl, 4.7 CsCl, 1.2 MgCl2, 0.01 CaCl2, 10 HEPES, 5.6 dextrose adjusted to pH 7.4 with NaOH). Cells were voltage-clamped at 0 mV and 500 ms voltage ramps from -80 mV to +80 mV were applied every second. Currents evoked by voltage ramps were Imaging of membrane-bound mitochondria: nt-HEK293, hTRPA1-HEK and hTRPV1-HEK on coverslips were incubated for 30 min at 37 o C with MitoTracker® Orange CMTMRos (250-500 ng/ml; Life Technologies, NY, USA). Cells were then perfused using whole-cell bath solution and inside-out excised patches pulled using pipettes backfilled with whole-cell pipette solution as described above. Fluorescence was observed using an X-Cite 120Q fluorescent light source and a rhodamine filter. Images were obtained using a Retiga Exi Fast 1394 camera and captured using QCapture software (QImaging, BC, Canada).
Statistical analysis: Data was analyzed using GraphPad software. Where appropriate paired or unpaired Student's T-test were used. A p value less than 0.05 was taken as significant. All data expressed as mean ± SEM unless otherwise noted.
This article has not been copyedited and formatted. The final version may differ from this version. was purchased from TEFLabs (Austin, TX). 5'-Iodoresiniferatoxin was purchased from Alomone labs (Israel).
Results

Mitochondrial modulation activates nociceptive airway vagal nerves
To test whether modulation of nerve terminal mitochondria play a role in vagal sensory nerve activation we used the selective ETC complex III inhibitor antimycin A. Antimycin A inhibits the Q i site on complex III, redirecting electrons along the transport chain and causing the incomplete reduction of available O 2 , thus resulting in superoxide formation in isolated mitochondria (10nM to 10 μ M) (Gyulkhandanyan and Pennefather, 2004; Potter and Reif, 1952; Slater, 1973; Stowe and Camara, 2009; Turrens et al., 1985) and intact cells (0.5 to 50 μ M) (Gonzalez-Dosal et al., 2012; Kim and Usachev, 2009; Li et al., 2003; Liu et al., 2010) . To study the mitochondria that are densely packed within bronchopulmonary sensory nerve terminals (von During and Andres, 1988), we have used a mouse ex vivo lung-vagal ganglia preparation in which drug treatments are perfused through the isolated lung and the action potential discharge of individual bronchopulmonary sensory nerves is recorded by an extracellular electrode micro-positioned in the vagal ganglia. The majority of bronchopulmonary sensory fibers are slowly conducting nociceptive c-fibers that serve to protect the airways from noxious stimuli by evoking defensive reflexes (Carr and Undem, 2003) . We have previously shown that these nociceptive fibers express TRPV1 and TRPA1 channels (Nassenstein et al., 2008; Taylor- This article has not been copyedited and formatted. The final version may differ from this version. concentrations previously shown to be selective for specific TRP channels (Caterina et al., 1997; Jordt et al., 2004; Kollarik et al., 2003; Macpherson et al., 2007; Nassenstein et al., 2008) .
As expected, capsaicin activated the vast majority of slowly conducting c-fibers (conduction velocity < 0.7m/s, mean peak response 14.2±1.9Hz) (Kollarik et al., 2003) . Approximately half of these nociceptive-like fibers (46/86) also responded to TRPA1 agonists. Fast conducting (>0.7m/s) fibers did not respond to either TRPA1 or TRPV1 agonists, which is consistent with previous reports describing the non-nociceptive nature of fast conducting airway nerves (Kollarik et al., 2003; Undem et al., 2004) .
We chose the concentration of 20μM antimycin A for these neuronal studies based upon previous studies in intact cells (Gonzalez-Dosal et al., 2012; Kim and Usachev, 2009; Li et al., 2003; Liu et al., 2010) . This concentration is expected to produce near maximal inhibition of complex III and evoke substantial superoxide production. Antimycin A (20μM) caused robust action potential discharge in slowly-conducting nociceptive (i.e. TRPV1-expressing) sensory nerves ( Fig 1A) . The peak discharge in response to antimycin A in TRPA1-expressing nociceptors (7.5 ± 1.9 Hz, n=17) was significantly higher than in nociceptors not expressing TRPA1 (2.5 ± 1.0 Hz, n=22, p<0.02). Antimycin A failed to activate non-nociceptors (0.5 ± 0.4
Hz, n=11). These results suggest that acute modulation of sensory nerve terminal mitochondria selectively activates a major subset of nociceptive nerves innervating the airways. Regardless of conduction velocity or sensitivity to TRP channel ligands, these bronchopulmonary fibers continued to demonstrate electrical excitability up to 1 hour after antimycin A treatment.
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TRPA1 and TRPV1 channels are critical for mitochondrial modulation-induced nerve activation
Given that acute mitochondrial modulation by antimycin A is likely to produce ROS and that ROS are capable of activating TRPA1 (Andersson et al., 2008; Sawada et al., 2008; Takahashi et al., 2008) and TRPV1 (Chuang and Lin, 2009; Susankova et al., 2006; Taylor-Clark et al., 2008a) , we hypothesized that the selective activation of vagal nociceptors by antimycin A was due to the indirect gating of these channels. We first addressed this hypothesis using the selective TRPA1 inhibitor HC-030031 (IC 50 ~1 μ M, (McNamara et al., 2007) ) and the selective TRPV1 inhibitor I-RTX (IC 50 ~5 nM, (Wahl et al., 2001 (Fig 2A and C) . As expected HC-030031 abolished AITC-induced neuronal activation but had no effect of capsaicin responses (data not shown). Three minute perfusion pretreatment with the selective TRPV1 inhibitor I-RTX (500 nM) also reduced antimycin A-induced neuron activation, albeit to a lesser extent (mean response 17.3 ± 2.2%, n=165 p<0.05). As expected I-RTX abolished capsaicin-induced neuronal activation but had no effect of AITC responses (data not shown). These findings were supported by complementary knockout studies (Fig 2B and C) .
Antimycin A evoked significantly less Ca²⁺ influx in vagal sensory neurons derived from TRPA1¯/¯ mice (mean response 11.3 ± 1.7%, n=81, p<0.05) compared to wild-type neurons.
Responses to antimycin A were also reduced in vagal sensory neurons from TRPV1¯/¯ mice (mean response 21.3 ± 1.4%, n=137, p<0.05). There was no significant difference between the pharmacological inhibition and genetic ablation of TRPA1 in decreasing antimycin A-induced Ca 2+ influx. There was also no significant difference between the pharmacological inhibition and genetic ablation of TRPV1 in decreasing antimycin A-induced Ca 2+ influx. These studies suggest that both TRPA1 and TRPV1 contribute to antimycin A-induced neuronal responses.
Furthermore, antimycin A-induced activation was completely abolished in TRPA1¯/¯ mouse vagal neurons in the presence of TRPV1 inhibitor I-RTX (mean 0.0 ± 0.8%, n=50, p<0.05) ( Fig   2B and C) . Thus the Ca²⁺ influx evoked by acute mitochondrial modulation is dependent mostly on the activation of TRPA1 and, to a lesser extent, TRPV1.
We next studied the mechanism underlying the action potential discharge from bronchopulmonary C-fiber terminals evoked by antimycin A (Fig 3) . Again, fibers were identified as 'TRPA1-expressing' by their response to selective TRPA1 ligands (cinnamaldehyde and This article has not been copyedited and formatted. The final version may differ from this version. decreased antimycin A-induced action potential discharge (peak discharge of 1.6 ± 0.7 Hz, n=9, p<0.01) compared to control (7.5 ± 1.9 Hz), suggesting that TRPA1 channels are critical to the initiation of action potentials from the nerve terminal (Fig 3, left) . Consistent with our hypothesis indicating that neuronal mitochondrially-derived ROS (see below) are sufficient to mediate antimycin A-induced nerve activation, ten minute pretreatment with a membrane-impermeable antioxidant glutathione (GSH, 3mM) had no effect on antimycin A-induced action potential discharge (7.8 ± 2.6 Hz, n=5, p>0.4). Our studies also demonstrated a possible role of TRPV1 in the nerve terminal responses to mitochondrial modulation. Antimycin A evoked decreased action potential discharge from TRPA1-expressing fibers from TRPV1¯/¯ mice (peak discharge 4.3 ± 1.2Hz, n=10, p=0.08), although this did not reach significance compared with controls (Fig   3, middle) . However, in wild-type nociceptors that did not express TRPA1 (as determined by a lack of response to TRPA1 selective agonist), the TRPV1 inhibitor I-RTX (1 μ M) produced a significant reduction in Antimycin A-induced nerve activation (peak discharge 0.6 ± 0.3 Hz, n=10, p=0.07; compared to 2.5 ± 1.0 Hz, n=22 without I-RTX), indicating the residual non-TRPA1-mediated antimycin A-induced action potential discharge was due to the activation of TRPV1 (Fig 3, right) . Therefore, similar to findings in dissociated vagal neurons, the action potential discharge in bronchopulmonary C-fibers evoked by antimycin A was due to the activation of TRPA1 and, to a lesser extent, TRPV1.
Mitochondrial modulation activates TRPA1 and TRPV1 in HEK 293 cells
This article has not been copyedited and formatted. The final version may differ from this version. (Fig 4A and B) . (Fig 4A and B) .
We investigated the effect of antimycin A on TRP channel currents using whole cell patch clamp electrophysiology. In order to maximize the putative TRP currents following antimycin A treatment we chose to use 10 μ M antimycin A (identified as a maximal dose in our Ca 2+ imaging studies of HEK293 cells). In order to prevent rundown of TRPA1 currents, we added 5mM Natriphosphate to the pipette solution (Kim and Cavanaugh, 2007) . In these studies, outwardly rectifying currents (reversing at 0mV) were evoked by AITC and capsaicin as expected: HEK 1 8 +70mV; capsaicin: -389 ± 128 at -70mV, 948 ± 194 pA at +70mV (p<0.01))(data not shown).
Antimycin A (10 μ M) failed to increase currents in nt-HEK cells (n=5) (Fig 5A) . However, we found that antimycin A evoked outwardly rectifying currents in HEKs transfected with TRPA1 (n=16, p<0.001) that were subsequently inhibited by the selective TRPA1 inhibitor HC-030031 (30μM, n=6, p<0.01) (Fig 5B) . In whole cell patch clamp recordings of hTRPV1-HEK cells, antimycin A (10μM) failed to evoke detectable currents (n=5, data not shown). However in gramicidin-perforated patch clamp recordings antimycin A (10 μ M) evoked small but significant outwardly rectifying currents (n=7, p<0.05) that were subsequently inhibited by the TRP channel blocker ruthenium red (30μM, p<0.05) (Fig 5C) . In addition, in one cell antimycin A-induced hTRPV1 currents were abolished by the selective TRPV1 inhibitor I-RTX (500nM, data not shown). The lack of detectable currents in whole cell patch clamp recordings of hTRPV1-HEK cells may be due to the combination of a weak activation of TRPV1 following acute mitochondrial modulation and the dilution of soluble factors required for the channel activation.
Mechanism of antimycin A-induced TRPA1 activation
Given the preferential role of TRPA1 in mitochondrial modulation-induced nociceptive neuronal activation, we further investigated the mechanism underlying the TRPA1 activation. TRPA1 can be activated through multiple mechanisms, including N-terminal cysteine modification (by ROS and lipid peroxidation products) (Hinman et al., 2006; Macpherson et al., 2007) , intracellular Ca²⁺ (Zurborg et al., 2007) , and noxious cold temperatures (Story et al., 2003) . Selective inhibition of the Q i site in mitochondrial ETC complex III by antimycin A (≤50 μ M) causes mitochondrial membrane potential depolarization and substantial superoxide production (Gyulkhandanyan and Pennefather, 2004; Potter and Reif, 1952; Slater, 1973; Stowe and Camara, 2009; Turrens et al., 1985) . Given TRPA1's sensitivity to ROS and downstream lipid peroxidation products we therefore hypothesized that antimycin A activated TRPA1 indirectly via This article has not been copyedited and formatted. The final version may differ from this version. the mitochondrial production of ROS. TRPA1 is rapidly activated following antimycin A treatment (see Fig 4) . Given the difficulty in complete elimination of evoked mitochondrial ROS within this limited timeframe (and prior to TRPA1 activation), we chose to use 2 μ M antimycin A (approximately EC 50 for TRPA1 activation) in the following mechanistic studies.
We first addressed this hypothesis using myxothiazol, an inhibitor of the Q o site on complex III.
Inhibition of Q o causes mitochondrial membrane potential depolarization but only very mild superoxide production (Gyulkhandanyan and Pennefather, 2004; Tretter et al., 2007; Turrens et al., 1985) . Furthermore, selective inhibition of Q o (myxothiazol) substantially reduces subsequent superoxide production evoked by inhibition of the Q i site (antimycin A) (Gyulkhandanyan and Pennefather, 2004; Tretter et al., 2007; Turrens et al., 1985) . Myxothiazol μ M antimycin A-induced TRPA1 activation was reduced (peak response 10.8 ± 2.0% ionomycin) compared to controls (peak response 35.6 ± 2.1% ionomycin, n=103, p<0.05) (Fig 6A) . Importantly, direct activation of hTRPA1 by AITC (100 μ M) was unaffected by myxothiazol pretreatment. Thus we conclude that antimycin A indirectly activates TRPA1 in a manner that is dependent on superoxide production from the Q i site of complex III.
Superoxide can be converted into H 2 O 2 by superoxide dismutase (SOD) enzymes in both the mitochondrial matrix (SOD2) and the cytosol (SOD1); H 2 O 2 is then broken down by catalase.
Both superoxide and H 2 O 2 have been shown to activate TRPA1 (Andersson et al., 2008; Sawada et al., 2008; Takahashi et al., 2008) . To investigate the role of ROS in mitochondrial modulation-induced TRPA1 activation we used tempol (SOD mimetic (Krishna et al., 1996) ) and
This article has not been copyedited and formatted. The final version may differ from this version. MnTMPyP (combined SOD and catalase mimetic (Day et al., 1997; Faulkner et al., 1994) 
ROS can activate TRPA1 directly through reversible modification of N-terminal cysteines (Andersson et al., 2008; Takahashi et al., 2008 ). In addition ROS are able to initiate peroxidation of unsaturated phospholipids (Karihtala and Soini, 2007) , increasing the local concentration of compounds with α,β-unsaturated carbonyl moieties (e.g. 4-hydoxynonenal) that directly activate TRPA1 through modification of N-terminal cysteines via Michael addition reactions (Trevisani et al., 2007) . We investigated the mechanism by which ROS evoked by mitochondrial modulation activated TRPA1 (direct vs. indirect) using the reducing agent dithiothreitol (DTT). DTT prevents and reverses sulfhydryl group oxidation/disulfide bond formation of exposed cysteine residues by hydrogen peroxide and other ROS (Getz et al., 1999) , and has previously been shown to prevent and reverse TRPA1 activation by these compounds (Andersson et al., 2008; Sawada et al., 2008; Takahashi et al., 2008) . However DTT has no effect on cysteine modifications by α,β-unsaturated carbonyl moieties (Michael reactions) and consequently DTT has no effect on TRPA1 activation by lipid peroxidation products (Andersson et al., 2008; Macpherson et al., 2007; Takahashi et al., 2008) . Three activation (peak response 2.7 ± 2.4% ionomycin, n=266)(p<0.05 compared to control: peak response 53.7 ± 2.7% (n=269))( Fig 6D) . As expected neither 1mM or 10mM DTT had any effect on AITC-induced TRPA1 activation (Fig 6E and data not shown) . This data indicates that TRPA1 activation downstream of mitochondrial modulation is not dependent on Michael addition by α,β-unsaturated carbonyl moieties, suggesting a direct (DTT-sensitive) activation by mitochondrially-produced ROS.
Together the myxothiazol, tempol/MnTMPyP and DTT studies are consistent with ROS mediating mitochondrial modulation-induced TRPA1 activation as opposed to a direct effect of antimycin A on TRPA1 N-terminal cysteines. Direct modification of model thiol groups can be determined using spectrophotometry and Ellman's reagent (5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB)). Reduction of DTNB using DTT produces 2-nitro-5-thiobenzoate (NTB) that absorbs strongly at 412nm. NTB is a free thiol group that, when modified by a cysteine-reactive compound, loses its absorption at 412nm. To confirm that antimycin A does not directly modify thiol groups we compared antimycin A with cinnamaldehyde and iodoacetamide (both direct TRPA1 agonists via cysteine modification (Macpherson et al., 2007) We lastly studied the effect of antimycin A on single TRP channel currents in excised inside-out patches from TRP-expressing HEK cells. In order to prevent rundown of TRPA1 currents, we added 5mM Na-triphosphate to the extracellular solution (Kim and Cavanaugh, 2007 +40mV, whose open probabilities were increased by AITC (10 μ M, n=5) (Fig 7A and B) .
Similarly, we identified stochastic conductances in hTRPV1 expressing cells of 121 (SD 66 pS, n=4) at +40mV, whose open probabilities were increased by capsaicin (300 nM, n=4) (Fig 7A   and B) . We predicted that antimycin A would have little effect on excised patches containing TRP channels based on the expectation that excised patches would be devoid of cytosolic organelles. Surprisingly, antimycin A (10 μ M) evoked a significant increase in the probability of stochastic conductances in TRPA1 expressing patches (n=7) consistent with hTRPA1 activation (Fig 7C, D and E) . Antimycin A (10 μ M) had no effect on excised patches from nt-HEK cells (n=4) or on the probability of TRPV1 opening in patches from hTRPV1 expressing cells (n=4).
Based upon our Ca 2+ imaging studies, we hypothesized that antimycin A increased TRPA1
single channel gating downstream of mitochondrial ROS. As such we hypothesized that functional mitochondria, lying close to the HEK 293 cell membrane, were taken up along with the excised membrane during the act of inside-out patch excision, as has been previously shown in pancreatic B-cells (Rustenbeck et al., 1999) . Using the mitochondrial-specific fluorescent probe Mitotracker® Orange, we found specific mitochondrial fluorescence in 5 out of 5 inside-out patches from nt-HEK cells, 5 out of 5 patches from stably transfected hTRPA1-HEK and 3 out of 3 patches from stably transfected hTRPV1-HEK (Fig 7F and G and data not shown). To confirm that excised patch mitochondria were responsible for the antimycin Ainduced TRPA1 activation, we pretreated the inside-out patch for 4 min with a combination of tempol (100 μ M), SOD (10 units/ml) and catalase (100 units/ml). ROS scavenging by this combination of tempol and enzymes significantly inhibited the antimycin A-induced increase in TRPA1 open probabilities (n=4, p<0.05). Similar to the Ca 2+ imaging studies, the scavenging of ROS had no effect on direct activation of TRPA1 by AITC (10 μ M, data not shown).
Discussion
This article has not been copyedited and formatted. The final version may differ from this version. Mitochondrial function is altered in airway inflammatory disease states such as asthma and COPD (Aguilera-Aguirre et al., 2009; Mabalirajan et al., 2008; Rabinovich et al., 2007) . Given that peripheral sensory nerve terminals are densely packed with mitochondria (Hung et al., 1973; von During and Andres, 1988) , we investigated the effect of mitochondrial modulation on sensory nerve function. In the present study we have shown that acute mitochondrial dysfunction selectively activates nociceptive vagal nerves and fails to activate non-nociceptive nerves. Nociceptive nerves protect the innervated organ through the initiation of reflexes and behavioral responses (Carr and Undem, 2003) . Thus we present evidence of a novel mechanism by which nocifensive airway responses can be evoked.
We found that 20 is activated by capsaicin, protons, heat and inflammatory mediators (Caterina et al., 1997; Hwang et al., 2000) and there is evidence to suggest that TRPV1 is also activated by certain electrophilic compounds (Salazar et al., 2008; Taylor-Clark et al., 2008a) . Here, consistent with our neuronal data, we found that in heterologous cell systems both TRPA1 and TRPV1 were activated by antimycin A. Antimycin A induced Ca 2+ influx and evoked outwardly rectifying currents in hTRPA1 and hTRPV1 expressing HEK cells that were blocked by the selective TRPA1 inhibitor HC-030031 and the TRP channel blocker ruthenium red, respectively. Both Ca 2+ imaging and whole cell patch data indicated that TRPA1 was more robustly activated following mitochondrial modulation than TRPV1. Antimycin A activated heterologouslyexpressed TRPA1 between 0.5 μ M and 20 μ M, consistent with previous reports of superoxide production by antimycin A at these concentrations in intact cells (Gonzalez-Dosal et al., 2012; Kim and Usachev, 2009; Li et al., 2003; Liu et al., 2010 (Gyulkhandanyan and Pennefather, 2004; Tretter et al., 2007; Turrens et al., 1985) .
Myxothiazol reduced antimycin A-induced hTRPA1 activation in Ca 2+ imaging studies, indicating that superoxide production from mitochondria was critical for TRPA1 activation. In some systems the complex I inhibitor rotenone has been shown to reduce antimycin A-induced superoxide production (Stowe and Camara, 2009 ). However, in intact cells with normal glycolysis/citric acid cycle rotenone can also evoke superoxide production from mitochondria (Gyulkhandanyan and Pennefather, 2004; Li et al., 2003; Stowe and Camara, 2009) . We found that rotenone (500nM) caused selective activation of TRPA1 but also reduced antimycin Ainduced TRPA1 activation (data not shown). Further investigation is required to determine whether antimycin A-induced TRPA1 activation is inhibited by rotenone due to a reduction in evoked ROS or due to desensitization of TRPA1 to ROS.
This article has not been copyedited and formatted. The final version may differ from this version. has been shown to activate TRPA1 directly through DTT-sensitive oxidation of N-terminal cysteines (Andersson et al., 2008; Sawada et al., 2008; Takahashi et al., 2008) . Exogenously applied superoxide also activates heterologously expressed TRPA1 channels (Sawada et al., 2008) (Andersson et al., 2008; Takahashi et al., 2008) : DTT reverses sulfhydryl group oxidation/disulfide bond formation of exposed cysteine residues but cannot reverse sulfhydryl modification by Michael addition reactions (Getz et al., 1999 concentrations. Further studies are required to confirm this ROS-dependent mechanism in the TRP-dependent activation of native neurons by mitochondrial dysfunction.
TRPA1 was highly sensitive to mitochondrial modulation by antimycin, to the extent that superoxide production by very limited numbers of mitochondria in excised patches (likely < 3, based upon space restrictions) were capable of significant ROS-mediated channel activation within a short time frame (< 20s). There remains the minor possibility that there was a direct interaction between antimycin A and TRPA1 in excised patches, although both the sensitivity of antimycin A-induced TRPA1 activation to ROS scavengers and the lack of cysteine-modification by antimycin A argues against this hypothesis. We briefly investigated the possibility that TRPA1 was, in addition to being expressed on the plasma membrane, also expressed in mitochondria. Using a V5-tagged hTRPA1 protein and the mitochondrial-specific fluorescent probe Mitotracker® Orange, we found no co-localization of TRPA1 (detected by primary antibody against V5) with Mitotracker® Orange following channel overexpression in HEK293 as determined by confocal microscopy (data not shown), indicating that TRPA1 is not a mitochondrial protein.
Our finding that mitochondrial dysfunction is sufficient to evoke airway sensory nerve activation is likely to be relevant for other sensory nerve types. Mitochondrial dysfunction and subsequent ROS production occurs in diseases such as type II diabetes, irritable bowel syndrome and cardiovascular disease (Chowdhury et al., 2012; Hall and Wiley, 1998; Rocha et al., 2010) . As such we predict that mitochondrial-TRPA1 interactions may contribute to nociceptor activation in these pathologies. In the airways, mitochondrial dysfunction and oxidative stress has been demonstrated for an array of cell types both in asthma and chronic obstructive bronchitis (Rabinovich et al., 2007; Reddy, 2011) , and can be initiated by a wide variety of inflammatory signaling pathways common in respiratory diseases: e.g. TNFα (Corda et al., 2001 ), This article has not been copyedited and formatted. The final version may differ from this version. neurotrophins via p75NTR (Pehar et al., 2007) , microRNAs (Aroor et al., 2012) , TGFβ (Michaeloudes et al., 2010) and Toll-like Receptors (West et al., 2011) . Airway vagal nociceptor activation and hyperexcitability contribute to cough, dyspnea, bronchospasm and hypersecretion (Carr and Undem, 2003) . Given the abundance of mitochondria at the sensory nerve termini and their susceptibility to various inflammatory mediators we suggest that mitochondrial dysfunction-induced sensory nerve activation represents a novel mechanism by which inflammation is transduced into nociceptive electrical signaling and thus contributes to the symptoms of airway disease. Lastly, our data show that under the present conditions of acute mitochondrial dysfunction vagal bronchopulmonary C-fibers and vagal dissociated neurons respond adequately to further stimulation (mechanical, chemical and electrical), suggesting that mitochondrial dysfunction (and subsequent oxidative stress) does not necessarily lead to cytotoxicity. Whether chronic mitochondrial dysfunction occurs in airway sensory nerves in inflammatory lung disease is a concept that requires further study. This article has not been copyedited and formatted. The final version may differ from this version. 
